News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
Cigna sues, wants leeway to tell customers which pharmacies to use
In 2019, Minnesota passed the Minnesota Pharmacy Benefit Manager Licensure and Regulation Act. It prevents Pharmacy Benefit Managers or PBMs from requiring customers on an insurance plan to go to a pharmacy that the PBM owns, often by mail order.
PBM Prime Therapeutics to Pay $10 Million Antitrust Case Over Price-Fixing Scheme with Express Scripts, Inc.
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and Blue Shield Plans, was found guilty of engaging in horizontal price-fixing in collaboration with Express Scripts, Inc. (ESI), a competitor owned by Cigna.
Legalized Racketeering? How PBMs Skirt the Law to Rake in Billions
Pharmacy Benefit Managers (PBMs) have been under scrutiny lately for their actions as middlemen in the flow of prescription drugs from manufacturers to patients. But perhaps their worst actions are buried within a maze of consolidation and paperwork. Big Insurance has consolidated the entire pharmaceutical benefit, claim, and dispensing sector to squeeze as much money out of patients as possible.
Bruised by Government Report, Cigna's Pharmacy Business Sues the Federal Trade Commission
Whistleblower, former Cigna VP, and reformed insurance propagandist Wendell Potter takes you behind the scenes to provide a glimpse into the reasoning behind the lawsuit his former company filed this week against the Federal Trade Commission (FTC).
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) are driving up drug costs for millions of people, employers and the government.
The second in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.